Xponance Inc. Boosts Holdings in Crocs, Inc. (NASDAQ:CROX)

Xponance Inc. raised its stake in shares of Crocs, Inc. (NASDAQ:CROX) by 1.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,052 shares of the textile maker’s stock after buying an additional 177 shares during the quarter. Xponance Inc.’s holdings in Crocs were worth $1,313,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Byrne Asset Management LLC grew its stake in Crocs by 60.0% during the fourth quarter. Byrne Asset Management LLC now owns 320 shares of the textile maker’s stock valued at $30,000 after acquiring an additional 120 shares in the last quarter. Blue Trust Inc. grew its position in shares of Crocs by 185.0% during the fourth quarter. Blue Trust Inc. now owns 342 shares of the textile maker’s stock valued at $32,000 after purchasing an additional 222 shares in the last quarter. Mendota Financial Group LLC increased its holdings in shares of Crocs by 50.6% in the fourth quarter. Mendota Financial Group LLC now owns 810 shares of the textile maker’s stock worth $76,000 after purchasing an additional 272 shares during the last quarter. CWM LLC lifted its position in shares of Crocs by 116.9% in the third quarter. CWM LLC now owns 1,063 shares of the textile maker’s stock worth $94,000 after buying an additional 573 shares in the last quarter. Finally, NBC Securities Inc. bought a new position in Crocs during the third quarter valued at approximately $124,000. Institutional investors own 93.44% of the company’s stock.

Crocs Trading Down 0.5 %

CROX opened at $125.77 on Thursday. The company has a debt-to-equity ratio of 1.13, a quick ratio of 0.75 and a current ratio of 1.30. The stock’s 50 day moving average price is $128.14 and its 200-day moving average price is $107.07. Crocs, Inc. has a one year low of $74.00 and a one year high of $150.56. The stock has a market cap of $7.61 billion, a price-to-earnings ratio of 9.82, a P/E/G ratio of 1.58 and a beta of 2.01.

Crocs (NASDAQ:CROX) last announced its quarterly earnings data on Thursday, February 15th. The textile maker reported $2.58 EPS for the quarter, beating the consensus estimate of $2.38 by $0.20. Crocs had a return on equity of 61.97% and a net margin of 20.00%. The company had revenue of $960.10 million for the quarter, compared to the consensus estimate of $958.39 million. During the same quarter in the prior year, the company posted $2.65 EPS. Crocs’s quarterly revenue was up 1.6% on a year-over-year basis. On average, equities analysts forecast that Crocs, Inc. will post 12.46 EPS for the current year.

Insider Buying and Selling

In related news, Director John B. Replogle acquired 1,972 shares of the stock in a transaction on Thursday, March 14th. The stock was bought at an average cost of $126.75 per share, with a total value of $249,951.00. Following the transaction, the director now directly owns 3,153 shares in the company, valued at $399,642.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director John B. Replogle acquired 1,972 shares of the firm’s stock in a transaction that occurred on Thursday, March 14th. The stock was purchased at an average cost of $126.75 per share, for a total transaction of $249,951.00. Following the completion of the acquisition, the director now directly owns 3,153 shares of the company’s stock, valued at approximately $399,642.75. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Daniel P. Hart sold 10,000 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $118.48, for a total transaction of $1,184,800.00. Following the transaction, the executive vice president now directly owns 219,293 shares in the company, valued at approximately $25,981,834.64. The disclosure for this sale can be found here. Insiders have sold 39,867 shares of company stock valued at $4,786,276 in the last 90 days. Company insiders own 2.69% of the company’s stock.

Analysts Set New Price Targets

CROX has been the topic of a number of research reports. Williams Trading reaffirmed a “hold” rating and issued a $125.00 price objective (down previously from $135.00) on shares of Crocs in a research note on Tuesday, April 16th. Raymond James boosted their price target on shares of Crocs from $120.00 to $145.00 and gave the stock a “strong-buy” rating in a research report on Friday, February 16th. Bank of America increased their price objective on shares of Crocs from $140.00 to $150.00 and gave the company a “buy” rating in a research report on Wednesday, March 20th. Stifel Nicolaus lifted their price objective on shares of Crocs from $132.00 to $140.00 and gave the stock a “buy” rating in a research note on Friday, February 16th. Finally, Barclays began coverage on shares of Crocs in a research report on Monday, April 1st. They set an “overweight” rating and a $167.00 target price on the stock. Four analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $145.17.

Crocs Profile

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.